Source: Annual Congress 2001 - Pulmonary thromboembolism and infections
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Rapti, E. Katsouda, E. Tsaroucha, D. Malamis, Z. Panagopoulos, J. Christakopoulou, O. Anagnostopoulou (Athens, Greece). Randomized trial of low-molecular-weight heparin compared with unfractionated heparin for acute pulmonary embolism. Eur Respir J 2001; 16: Suppl. 31, 2615

Member's Comments

No comment yet.

Related content which might interest you: Enoxaparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Low-molecular-weight heparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 381s Year: 2001 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE Source: Eur Respir J 2005; 26: Suppl. 49, 699s Year: 2005 Comparison between the administration of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) in the treatment of pulmonary embolism Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 One hour alteplase infusion plus low molecular weight heparin versus heparin alone in pulmonary embolism Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Comparison of long –term outcomes of 50 mg rt-PA and 100 mg rt-PA in the management of acute pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 Efficacy of thrombolytic agents in the treatment of pulmonary embolism Source: Eur Respir J 2005; 26: 864-874 Year: 2005 Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials Source: Eur Respir J, 50 (3) 1701097; 10.1183/13993003.01097-2017 Year: 2017 Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin. Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 A case-control study on direct oral anticoagulants versus warfarin for acute pulmonary embolism in obese patients Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Early discharge of patients with pulmonary embolism: a two-phase observational study Source: Eur Respir J 2007; 30: 708-714 Year: 2007 Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006